Cargando…

Serum 1,5-anhydroglucitol when used with fasting plasma glucose improves the efficiency of diabetes screening in a Chinese population

Serum 1,5-anhydroglucitol (1,5-AG) levels can not only accurately reflect the mean blood glucose over the previous 1–2 weeks in diabetic patients but also offers the advantage of representing postprandial glucose. To evaluate the clinical significance of 1,5-AG in diabetes detection, especially when...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ying, Lingwen, He, Xingxing, Ma, Xiaojing, Shen, Yun, Su, Hang, Peng, Jiahui, Wang, Yufei, Bao, Yuqian, Zhou, Jian, Jia, Weiping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5607288/ https://www.ncbi.nlm.nih.gov/pubmed/28931928 http://dx.doi.org/10.1038/s41598-017-12210-z

Ejemplares similares

Comparative Agreement Analysis of Differences in 1,5-Anhydroglucitol, Glycated Albumin, and Glycated Hemoglobin A1c Levels between Fasting and Postprandial States in Steamed Bread Meal Test
por: Su, Hang, et al.
Publicado: (2017)

Saliva 1,5-anhydroglucitol is associated with early-phase insulin secretion in Chinese patients with type 2 diabetes
por: Ying, Lingwen, et al.
Publicado: (2021)

Serum 1,5-Anhydroglucitol to Glycated Albumin Ratio Can Help Early Distinguish Fulminant Type 1 Diabetes Mellitus from Newly Onset Type 1A Diabetes Mellitus
por: Ying, Lingwen, et al.
Publicado: (2020)

Glycated albumin is more closely correlated with coronary artery disease than 1,5-anhydroglucitol and glycated hemoglobin A1c
por: Ma, Xiaojing, et al.
Publicado: (2015)

Elevated serum fibroblast growth factor 23 levels as an indicator of lower extremity atherosclerotic disease in Chinese patients with type 2 diabetes mellitus
por: He, Xingxing, et al.
Publicado: (2017)

Data for serum 1,5 anhydroglucitol concentration in different populations
por: Welter, Marciane, et al.
Publicado: (2018)

Association between 1,5-Anhydroglucitol and Acute C Peptide Response to Arginine among Patients with Type 2 Diabetes
por: Shen, Yun, et al.
Publicado: (2020)

Value of serum 1,5-anhydroglucitol measurements in childhood obesity in the continuum of diabetes
por: Yoo, Ha Yeong, et al.
Publicado: (2015)

Association between a biomarker of glucose spikes, 1,5-anhydroglucitol, and cancer mortality
por: Kira, Sakurako, et al.
Publicado: (2020)

Postload Glycated Albumin as an Alternate Measure for Diabetes Screening in a Chinese Population
por: Su, Hang, et al.
Publicado: (2018)

Association of 1,5-Anhydroglucitol With Cardiovascular Disease and Mortality
por: Selvin, Elizabeth, et al.
Publicado: (2016)

Evaluation of Serum 1,5 Anhydroglucitol Levels as a Clinical Test to Differentiate Subtypes of Diabetes
por: Pal, Aparna, et al.
Publicado: (2010)

Association of 1,5-Anhydroglucitol and 2-h Postprandial Blood Glucose in Type 2 Diabetic Patients
por: Stettler, Christoph, et al.
Publicado: (2008)

1,5-Anhydroglucitol as a Marker of Acute Hyperglycemia in Cardiovascular Events
por: Migała, Marta, et al.
Publicado: (2022)

Genome-wide association study of 1,5-anhydroglucitol identifies novel genetic loci linked to glucose metabolism
por: Li, Man, et al.
Publicado: (2017)

Serum levels of 1,5-anhydroglucitol and 1,5-anhydrofructose-derived advanced glycation end products in patients undergoing hemodialysis
por: Tanaka, Kenji, et al.
Publicado: (2021)

The association between serum growth differentiation factor 15 levels and lower extremity atherosclerotic disease is independent of body mass index in type 2 diabetes
por: He, Xingxing, et al.
Publicado: (2020)

Rational diagnoses of diabetes: the comparison of 1,5-anhydroglucitol with other glycemic markers
por: Malkan, Umit Yavuz, et al.
Publicado: (2015)

Salivary 1,5-Anhydroglucitol and Vitamin Levels in Relation to Caries Risk in Children
por: Syed, Sadatullah, et al.
Publicado: (2019)

Finding the clinical utility of 1,5-anhydroglucitol among primary care practitioners
por: Peabody, John, et al.
Publicado: (2020)

Serum Fibroblast Growth Factor 19 Levels Are Decreased in Chinese Subjects With Impaired Fasting Glucose and Inversely Associated With Fasting Plasma Glucose Levels
por: Fang, Qichen, et al.
Publicado: (2013)

An Efficient Electrochemical Biosensor to Determine 1,5-Anhydroglucitol with Persimmon-Tannin-Reduced Graphene Oxide-PtPd Nanocomposites
por: Li, Guiyin, et al.
Publicado: (2023)

A study on the association of serum 1,5-anhydroglucitol levels and the hyperglycaemic excursions as measured by continuous glucose monitoring system among people with type 2 diabetes in China
por: Wang, Y, et al.
Publicado: (2012)

Relationship of glycemic control markers - 1,5 anhydroglucitol, fructosamine, and glycated hemoglobin among Asian Indians with different degrees of glucose intolerance
por: Pramodkumar, Thyparambil Aravindakshan, et al.
Publicado: (2016)

Rare variants in SLC5A10 are associated with serum 1,5-anhydroglucitol (1,5-AG) in the Atherosclerosis Risk in Communities (ARIC) Study
por: Loomis, Stephanie J., et al.
Publicado: (2019)

Alternative biomarkers for assessing glycemic control in diabetes: fructosamine, glycated albumin, and 1,5-anhydroglucitol
por: Lee, Ji-Eun
Publicado: (2015)

Measurement of 1,5-anhydroglucitol in blood and saliva: from non-targeted metabolomics to biochemical assay
por: Halama, Anna, et al.
Publicado: (2016)

1,5-Anhydroglucitol Predicts Mortality in Patients with HBV-Related Acute-on-chronic Liver Failure
por: Zhang, Lingjian, et al.
Publicado: (2022)

Serum 1,5-Anhydroglucitol Concentrations Are a Reliable Index of Glycemic Control in Type 2 Diabetes With Mild or Moderate Renal Dysfunction
por: Kim, Won Jun, et al.
Publicado: (2012)

Effect of 1,5-anhydroglucitol levels on culprit plaque rupture in diabetic patients with acute coronary syndrome
por: Su, Gong, et al.
Publicado: (2020)

Salivary 1,5-Anhydroglucitol and its Correlation with Postprandial Hyperglycemia: Development and Validation of a Novel Assay
por: Kedarnath, Priyadarshini Subramaniam, et al.
Publicado: (2023)

Effect of Eating Glutinous Brown Rice Twice a Day for 6 Weeks on Serum 1,5-Anhydroglucitol in Japanese Subjects without Diabetes
por: Nakayama, Taiga, et al.
Publicado: (2020)

1,5-anhydroglucitol is a good predictor for the treatment effect of the Sodium-Glucose cotransporter 2 inhibitor in Japanese patients with type 2 diabetes mellitus
por: Usui, Masahiro, et al.
Publicado: (2020)

1,5-Anhydroglucitol as a Useful Marker for Assessing Short-Term Glycemic Excursions in Type 1 Diabetes
por: Seok, Hannah, et al.
Publicado: (2015)

Human and mouse non‐targeted metabolomics identify 1,5‐anhydroglucitol as SGLT2‐dependent glycemic marker
por: Kappel, Ben A., et al.
Publicado: (2021)

SGLT5 is the renal transporter for 1,5-anhydroglucitol, a major player in two rare forms of neutropenia
por: Diederich, Jennifer, et al.
Publicado: (2023)

Associations of Serum 25-Hydroxyvitamin D(3) Levels with Visceral Adipose Tissue in Chinese Men with Normal Glucose Tolerance
por: Hao, Yaping, et al.
Publicado: (2014)

Serum Glycated Albumin Is Inversely Influenced by Fat Mass and Visceral Adipose Tissue in Chinese with Normal Glucose Tolerance
por: Wang, Feifei, et al.
Publicado: (2012)

Nonlinear association of 1,5-anhydroglucitol with the prevalence and severity of coronary artery disease in chinese patients undergoing coronary angiography
por: Yang, Ruiyue, et al.
Publicado: (2022)

Glycemic variability assessed by continuous glucose monitoring and the risk of diabetic retinopathy in latent autoimmune diabetes of the adult and type 2 diabetes
por: Lu, Jingyi, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_hqj3m0078v9066e8fqpjd0om1p